Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder

The Pharmacogenomics Journal, Published online: 19 February 2021; doi:10.1038/s41397-021-00219-7Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder

Source: The Pharmacogenomics Journal - February 19, 2021 Category: Drugs & Pharmacology Authors: M. S. Zastrozhin V. Yu Skryabin A. E. Petukhov M. V. Torrado E. P. Pankratenko A. K. Zastrozhina E. A. Grishina K. A. Ryzhikova V. V. Shipitsyn E. A. Bryun D. A. Sychev Source Type: research